A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users
By removing the need for manual reconstitution before use, the pen simplifies preparation and helps maintain consistent handling throughout experimental protocols
Since both substances alone are hard on the heart, combining them ups the risk even more
Lyophilized peptides are stable at room temperature for short periods
28C short-term post-reconstitution Reconstitution: Use sterile laboratory-grade solvent (bacteriostatic water typical) Stability: Avoid repeated freeze/thaw cycles to maintain peptide integrity Country of Origin: USA fulfilled with batch continuity tracking Documentation: Batch-specific Certificate of Analysis available on request Packaging: Tamper-evident, with cold-chain packaging available when required Quality Standards and Documentation Every batch of Tesamorelin Ipamorelin supplied by Iron Labs is third-party analytically verified
See our overview of GLP-1, Semaglutide, and Tirzepatide and how our plans work